Hydrops: Diagnosing & Redefining Outcomes With Precision Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Hydrops: Diagnosing & Redefining Outcomes With Precision Study	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Edema, Female Urogenital Diseases and Pregnancy Complications, Fetal Anomalies, Fetal Diseases, Hemic and Lymphatic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, alpha thalassemia spectrum, fetal erythroblastosis, hematologic disorder, hereditary disease, hydrops fetalis, immune system disorder, inherited hemoglobinopathy, pregnancy disorder, thalassemia	Active, not recruiting	Not applicable	2026-04-17		NCT03412760

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	536
Fetal Health Foundation	1
National Institutes of Health (NIH)	667
University of California, San Francisco	637

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of California, San Francisco	San Francisco	United States	294